DDT (l,l, 1-trichloro-2,2-bis(p-chlorophenyl)ethane) is perhaps the best known insecticide manufactured. While its usage is now restricted in the United States and several other countries, it remains an environmental contaminant of toxicological concern. Widespread exposure of human populations to DDT is reflected by its prevalence in serum samples (Nhachi and Kasilo, 1990; Violante et al., 1986; D'Ercole et al., 1976) , and the potential for cumulative exposure is indicated by the positive correlation of human DDT levels with age (D'Ercole et al., 1976; MussaloRauhamaa et al., 1988; Kreiss et al., 1981) . In many ways, DDT is a prototype for those chlorinated compounds characterized as resistant to environmental degradation, bio-magnified in the food chain, poorly metabolized, and highly retained in the body (Murphy, 1986 ).
Women are a population of special significance with respect to organochlorine pesticide exposure, in part due to possible adverse effects on pregnancy. Of notable concern is that exposure to DDT and other organochlorine compounds has been associated with preterm birth in several mammalian species, including California sea lions (DeLong et al., 1973) rabbits (Hart et al., 1971 ) and humans (Saxena et al., 1980 (Saxena et al., , 1981 Wassermann et al., 1982) . A mechanistic basis for this association has not been explored. Although it has been suggested that chlorinated compounds may precipitate labor by altering hormonal status (Wassermann et al., 1982) , experimental support of this mechanism is lacking.
Technical grade DDT consists primarily of ~,a'-DDT and o,p'-DDT. The major metab-olite of DDT in humans is &-DDE; this is often the most common form of DDT detected in human tissues, although substantial amounts of p,p'-DDT, a,$-DDT, and p,p'-DDD have also been found (D'Ercole et al., 1976; Mussalo-Rauhamaa et al., 1988) . A recent report showed that o,p'-DDT, p,p'-DDT, and p,p'-DDD residues were detected in substantially greater amounts (l-13 ppm) in drinking water than was p,p'-DDE (0.05-0.09 ppm) (Dikshith et al., 1990) . This suggests that the p,p'-DDE levels observed in human tissue samples may reflect environmental exposure to DDT isomers other than p&-DDE, followed by human metabolism to p,p'-DDE. In our investigation, we chose the o,p'-DDT isomer because it has significant estrogenic effects on the uterus of numerous species, including rat, and it is a primary component of the technical grade preparation to which plants, animals, and humans are initially exposed (Galand et al., 1987) .
We recently reported that in vitro overnight exposure at 4°C to 100 PM o,p'-DDT stimulates subsequent contraction activity in rat uterine strips 199 1) . In the present study, we describe an improved testing protocol for assessment of uterine contraction frequency that provides stable, phasic contractile activity prior to exposure, and has allowed us to characterize the dose-and timerelated stimulatory effects of o,p'-DDT. The data show that the frequency of contraction increased in a dose and time dependent manner, even after removal of o.p'-DDT from the medium.
METHODS
Chemicals and solutions. o.p'-DDT (99% purity) was purchased from Crescent Chemical Co. (Hauppauge, NY). A stock solution of 20 mg/ml (56 mM) was prepared in absolute ethanol for use in all experiments.
Contractility assessment. Contraction frequency was quantified, since this was the contractility parameter found to be most affected by in vitro exposure to o,p'-DDT in an earlier study 199 I) . For each experiment. a single longitudinal strip was excised from the fetal side of one of the uterine horns of a midgestation (Day 10) Sprague-Dawley rat. and cut in tandem from cervical to ovarian end into four smaller strips (ca. 3 mm X IO mm). The smaller strips were assigned to an experimental group using a systematic coin toss: one of the two strips nearest to each end was assigned to a DDT group and the other strip at each end to a control group. In this manner, four strips from each animal were employed in each experimental run, two ofwhich were exposed to o,p'-DDT and two of which were exposed to solvent only (control). This assignment procedure was used to reduce bias that might be introduced by disproportionate grouping of strips derived from the cervical versus ovarian end of the horn, since there may be intrinsic differences between the two regions of the uterus (Lodge and Sproat, 1981) . To record isometric contractions. uterine strips were placed in 50-ml muscle baths (custom-made by the University of Michigan Glass Shop) containing physiological saline solution (PSS: 116 mM NaCI, 21.9 mM NaHCOj, 11.1 mM dextrose, 4.6 mM KCI. 1.16 mM MgS04(7H20), 1.16 mM NaH1P04(Hz0). 1.8 mM CaCl,(2H,O), pH 7.4). two strips per bath, and allowed to equilibrate for 1 hr at 37°C (95% 02/5% COZ). The strips were then attached to force transducers (Grass F-T-03, Quincy. MA) under 0.5 g passive tension, and the strips were depolarized with 60 mM KC1 to assess maximal contractile force. The baths were rinsed free of KCI and the equilibration period was continued for 4-6 hr until regular phasic contractile activity ensued in all preparations. The strips were then monitored for 1 hr. from which baseline frequency was calculated. Following the baseline period, uterine strips were dosed with o.p'-DDT at final concentrations of 10, SO. or 100 pM, or with equivalent volumes of solvent only (controls) at final concentrations of 0.02,0.09. or 0.17% (v/v) absolute ethanol. Contractions were monitored for 3 hr in the presence of test substance (treatment period), followed by 3 hr without test substance (post-treatment period). In order to maintain buffer capacity, the bathing solution was changed to fresh PSS 90 min into the treatment and post-treatment periods: replenishing PSS for the treatment period included the original concentrations of the test substance. At the conclusion of each experiment, uterine strips were again depolarized with 60 mM KC1 to assess maximal contractile force and to reaffirm tissue viability. A contraction was operationally defined as a spike which initiated at baseline, exceeded 50% maximal contraction, and returned to baseline. Six or seven experimental runs were conducted with each o.p'-DDT concentration. This procedure differs from most reports in the literature in that uterine activity is usually assessed within 30-60 min after placement in the muscle bath. The longer equilibration period used in our study generated highly stable spontaneous baseline contractility, which typically is not observed with shorter equilibration periods.
Dalu analysis. Mean contraction frequencies were calculated for the 1-hr baseline, 3-hr treatment, and 3-hr posttreatment periods. The mean contraction frequency of each pair of o.p'-DDT-treated or control strips was averaged over experimental runs to obtain a mean contraction frequency for each period and each treatment. The percentage increases cited in the text were based on contraction frequencies of o,p'-DDT-treated strips relative to control strips from the respective test period. To determine if the o,p'-DDT-treated strips differed from controls, we tested for the mean effect that the differences in mean contraction frequency between matched control and o,p'-DDT-treated strips equaled zero, the expected result if o.p'-DDT had no effect on contraction frequency (Winer. 197 1) . To determine dose and time effects as well as interaction between dose and time, the differences in mean contraction frequency between matched control and o,p'-DDT-treated strips were analyzed by repeated measures analysis of variance (ANOVA) followed by appropriate one-way ANOVAs (Winer, L97 1). A separate repeated measures ANOVA was also performed on the control data, to ascertain if the solvent, ethanol, used to dissolve a,~'-DDT. had an independent effect. Posthoc comparisons of means were performed using the Student-Newman-Keuls method (Winer. 197 I) . An 01 level of 0.05 was assumed in all analyses.
RESULTS
The dose and time effects of o,p'-DDT on uterine contraction frequency are summarized in Fig. 1 . During the treatment period, 10,50, and 100 PM o,p'-DDT increased contraction frequency by $23, and 66%, respectively, relative to controls; these differences were significant for the 50 and 100 I.LM o.p'-DDTtreated strips (a < 0.05). After removal of the test substance from the bathing medium, the contractions continued to increase during the post-treatment period, with concentrations of 50 and 100 PM o,p'-DDT increasing contraction frequency 39 and 104%, respectively, relative to controls (a < 0.05). Treatment with 10 PM o,n'-DDT decreased contraction frequency nonsignificantly by 0.3% relative to controls during the post-treatment period. No significant differences were detected between o,p'-DDT and control groups during the baseline period, as expected.
Analysis of the mean differences between o,p'-DDT-treated strips and matched controls showed that increases in contraction frequency were related to both dose and test period, with a significant interaction also observed ( Fig. 1; ANOVA dose, time, and interaction effects, p < 0.001). No significant differences were observed between the dose groups during the baseline period, as expected. During the treatment period, only 100 PM o,p'-DDT increased contraction frequency significantly greater than the baseline value (p -L 0.05). In the posttreatment period, the relative frequency of contraction continued to increase in uterine strips treated with either 50 or 100 I.LM o,p'-DDT, and was significantly greater than base-line in both groups (p < 0.05), despite the absence of DDT in the bath. A dose effect was observed during the post-treatment period, with the relative increase in contraction frequency of strips treated with 100 j.&M o,p'-DDT greater than strips treated with 50 or 10 PM o,p'-DDT (p < 0.05). Additionally, during the treatment period, 100 PM o,p'-DDT elicited significant increases of contraction frequency compared to 10 PM o,p'-DDT (p < 0.05).
A representative polygraph tracing depicting the increased frequency in uterine strips treated with 100 PM o,p'-DDT is shown in Fig.  2 . Although force was not statistically analyzed, 1.5-2.0 g of force per contraction was observed, with no apparent changes due to treatment or time in the muscle bath. Maximal contractile force, assessed prior to and after experimentation, exceeded 3.0 g in all preparations, indicating no loss of viability of the tissue.
Contraction frequencies of solvent controls for 10, 50, and 100 FM o,p'-DDT changed from baseline to treatment periods by + 10, +6, and -17%, respectively (Fig. 1) ; however, this effect was not statistically significant.
DISCUSSION
Modulation of uterine contractility by certain pharmacological agents is well-established (Mehrotra et al., 1985; Honnebier et al., 1989; Swahn and Bygdeman, 1988; Schrock et al., 1989; Tadmor et al., 1990) . However, the effects of environmental substances on smooth muscle excitation/contraction have received minimal attention. Despite evidence linking DDT exposure to preterm birth (Saxena et al., 1980 (Saxena et al., ,1981 Wassermann et al., 1982) , this is the first demonstration that o,p'-DDT directly stimulates uterine contractility in a dose-and time-related manner.
Because contraction frequency increased with dose, the response was dependent on the amount of o,p'-DDT added to the muscle bath. The fact that no effect was observed in strips treated with 10 /*M o,p'-DDT suggests that either a threshold exists for increased contraction frequency or that the techniques employed were insufficient to detect an observable response at this dose. It is notable that the frequency of contraction continued to increase in uterine strips treated with 50 and 100 j.bM o,p'-DDT even after removal of the compound from the bath. We suggest that either an appreciable amount of o,p'-DDT was retained by the tissue or that the DDT effect is not readily reversible. Because of DDT's lipophilicity, a significant amount may remain in the tissue following removal from the medium, consistent with in vivo data that indicate storage and bioaccumulation of such lipophilic compounds.
Unexpectedly, an inverse trend was observed between ethanol concentration and contraction frequency in the solvent controls. While not statistically significant, the decrease in contraction frequency observed in the controls for 100 I.LM o,p'-DDT may be due to ethanol inhibition of uterine contractility, since the phasic activity often ceased for a brief period of time following ethanol administration. Resumption of regular phasic activity, coupled with postexperiment assessment of maximal contractile force, suggests that the brief period of inactivity was not due to decreased tissue viability. Similar observations DDT decreases membrane potential in human of the inhibitory effect of ethanol on myoliver cells (Schefczik and Buff, 1984) and remetrium have been reported both in vivo and tards sodium channel inactivation in insect in vitro (Wilson et al., 1969; Lauersen et al., nerve (Beeman, 1982) . Other studies have 1981). The ethanol concentrations used in demonstrated DDT inhibition of cellular calthese experiments were determined by the sol-cium ATPases in lobster nerve (Ghiasuddin ubility of o, 198 1) and in human placenta Because inhibition was not observed in o,p'- (Treinen and Kulkarni, 1986 ) possibly re-DDT-treated strips, o,p'-DDT may prevent or sulting in altered cytosolic calcium. If such efoverride any inhibitory action of ethanol.
fects occurred in myometrium, the depolarWhile frequency of contraction is only one ization threshold of pacemaker cells could be measure of contractility, this was the paramlowered, increasing the rate of firing and reeter most prominently affected by o,p'-DDT sulting in increased contractility. Additionally, treatment. Occasionally, we observed that 100 o,p'-DDT is an estrogenic isomer of DDT PM o,p'-DDT initiated a change in the con-which interacts in a competitive manner with tractility pattern from increased regular con-the rat uterine estrogen receptor (Welch et al., tractions to one characterized by low-ampli-1969; Nelson, 1974) . Estrogens have multiple tude, high-frequency spike contractions. This effects on the uterus including stimulation of may be significant, since studies with women synthesis of the contractile proteins, actin and (not exposed to DDT) suggest that a similar myosin, and increased gap junctional compattern is observed more often in women who munication (Riemer and Roberts, 1986 ; subsequently deliver prematurely compared to MacKenzie et al., 1983) . If o,p'-DDT elicited those who deliver at term (Newman ei al., either of these cellular responses in myome-1987).
trium, improved propagation of action potenSerum levels of DDT in women who de-tials and contractions could result. velop preterm labor have been measured in In the present study, we have shown that the range of 0.1-0.6 pg/ml (Wassermann et o,p'-DDT significantly increased isometric al., 1982; Saxena et al., 1980 Saxena et al., ,1981 , while contraction frequency in a dose-and time-reother studies have shown serum levels of ex-lated manner. While these results do not proposed persons to be as high as 2.8 pg/ml vide an explanation for the association be- (Kreiss et al., 198 1) . These levels probably do tween DDT and preterm birth, we suggest that not represent the total body burden of DDT, the findings may be relevant since studies indue to DDT's ability and preference to reside dicate that the frequency of uterine contracin lipophilic stores; in fact, adipose/serum ra-tions is significantly greater in women who tios of 100-200 are not uncommon (Kreiss et subsequently develop preterm labor compared al., 198 1; Polishuk et al., 1970) . While the ef-to women who deliver at term (Katz et al., fective concentrations in our investigation are 1986; Bell, 1983) . In subsequent experiments, somewhat higher than those typically found we have obtained similar results with p,p'-in vivo, DDT is likely to be better solubilized DDT, p,p'-DDD, and technical grade DDT in serum and adipose tissue than in the saline (unpublished observations), and currently are buffer. The DDT concentrations in our study examining a mechanistic basis for these find-(3.5-35 pg/ml) are very similar to those effec-ings. tive levels in other studies which have used tissue and cell culture systems for investigation of DDT action (Price, 1978; Klaunig et al., ACKNOWLEDGMENTS 1990; Warngard et al., 1988 
